Kolonel LN - Search Results

1

Assessing the impact of population stratification on genetic association studies.

Freedman ML, Reich D, Penney KL, McDonald GJ, Mignault AA, Patterson N, Gabriel SB, Topol EJ, Smoller JW, Pato CN, Pato MT, Petryshen TL, Kolonel LN, Lander ES, Sklar P, Henderson B, Hirschhorn JN, Altshuler D. Freedman ML, et al. Among authors: kolonel ln. Nat Genet. 2004 Apr;36(4):388-93. doi: 10.1038/ng1333. Epub 2004 Mar 28. Nat Genet. 2004. PMID: 15052270

2

Evidence of an X-linked or recessive genetic component to prostate cancer risk.

Monroe KR, Yu MC, Kolonel LN, Coetzee GA, Wilkens LR, Ross RK, Henderson BE. Monroe KR, et al. Among authors: kolonel ln. Nat Med. 1995 Aug;1(8):827-9. doi: 10.1038/nm0895-827. Nat Med. 1995. PMID: 7585188

3

A prevalent missense substitution that modulates activity of prostatic steroid 5alpha-reductase.

Makridakis N, Ross RK, Pike MC, Chang L, Stanczyk FZ, Kolonel LN, Shi CY, Yu MC, Henderson BE, Reichardt JK. Makridakis N, et al. Among authors: kolonel ln. Cancer Res. 1997 Mar 15;57(6):1020-2. Cancer Res. 1997. PMID: 9067262

4

A polymorphism in the CYP17 gene increases the risk of breast cancer.

Feigelson HS, Coetzee GA, Kolonel LN, Ross RK, Henderson BE. Feigelson HS, et al. Among authors: kolonel ln. Cancer Res. 1997 Mar 15;57(6):1063-5. Cancer Res. 1997. PMID: 9067272

5

A polymorphism in intron 6 of the CYP17 gene.

Crocitto LE, Feigelson HS, Yu MC, Kolonel LN, Henderson BE, Coetzee GA. Crocitto LE, et al. Among authors: kolonel ln. Clin Genet. 1997 Jul;52(1):68-9. doi: 10.1111/j.1399-0004.1997.tb02519.x. Clin Genet. 1997. PMID: 9272718 No abstract available.

6

Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility.

Ross RK, Coetzee GA, Pearce CL, Reichardt JK, Bretsky P, Kolonel LN, Henderson BE, Lander E, Altshuler D, Daley G. Ross RK, et al. Among authors: kolonel ln. Eur Urol. 1999;35(5-6):355-61. doi: 10.1159/000019909. Eur Urol. 1999. PMID: 10325489 Review.

7

Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA.

Makridakis NM, Ross RK, Pike MC, Crocitto LE, Kolonel LN, Pearce CL, Henderson BE, Reichardt JK. Makridakis NM, et al. Among authors: kolonel ln. Lancet. 1999 Sep 18;354(9183):975-8. doi: 10.1016/S0140-6736(98)11282-5. Lancet. 1999. PMID: 10501358

8

Germ-line HER-2 variant and breast cancer risk by stage of disease.

McKean-Cowdin R, Kolonel LN, Press MF, Pike MC, Henderson BE. McKean-Cowdin R, et al. Among authors: kolonel ln. Cancer Res. 2001 Dec 1;61(23):8393-4. Cancer Res. 2001. PMID: 11731415

9

Steroid 5-alpha reductase type II V89L substitution is not associated with risk of prostate cancer in a multiethnic population study.

Pearce CL, Makridakis NM, Ross RK, Pike MC, Kolonel LN, Henderson BE, Reichardt JK. Pearce CL, et al. Among authors: kolonel ln. Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):417-8. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 11927504 No abstract available.

10

Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study.

Stram DO, Haiman CA, Hirschhorn JN, Altshuler D, Kolonel LN, Henderson BE, Pike MC. Stram DO, et al. Among authors: kolonel ln. Hum Hered. 2003;55(1):27-36. doi: 10.1159/000071807. Hum Hered. 2003. PMID: 12890923

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

639 results

Search Page